Brenntag (ETR:BNR) target price raised to 48.00EUR, reported today by Baader Wertpapierhandelsbank
- Updated: September 29, 2016
Yesterday Brenntag (ETR:BNR) traded 0.00% even at 48.85EUR. The company’s 50-day moving average is 0.00EUR and its 200-day moving average is 0.00EUR. The last stock close price is up 0.00% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 0 shares of the stock were exchanged, down from an average trading volume of 0
Brenntag (ETR:BNR) had its target price raised to 48.00EUR by Baader Wertpapierhandelsbank in a report released 9/29/2016. The new target price indicates a possible downside of -0.02% based on the company's last stock close price.
Previously on 9/12/2016, HSBC reported about Brenntag (ETR:BNR) raised the target price from 0.00EUR to 43.00EUR. At the time, this indicated a possible downside of -0.09%.
See Chart Below
Brenntag has a 52 week low of 0.00EUR and a 52 week high of 0.00EUR The company’s market cap is currently 0 EUR.
About Brenntag (ETR:BNR)
Brenntag AG is a Germany-based company active in the field of full-line chemical distribution. It provides business-to-business distribution solutions for industrial and specialty chemicals. The Company purchases and stores large-scale quantities of industrial and specialty chemicals and repackages them into smaller quantities. In addition, the Company also offers additional services, including delivery, product mixing, blending, repackaging, micronization and fine milling, inventory management and drum return handling, as well as technical and laboratory services for specialty chemicals. The Company offers its products to a range of market industries, such as adhesives, paints, oil & gas, food, water treatment, personal care and pharmaceuticals. The Company operates through a network with more than 450 locations in Europe, North and Latin America, and in the Asia Pacific region. Its subsidiaries include, among others, Quimicas Merono SL.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.